Summit Therapeutics Inc
NASDAQ:SMMT
Cash Flow Statement
Cash Flow Statement
Summit Therapeutics Inc
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||
| Net Income |
(37)
|
(48)
|
(53)
|
(70)
|
(73)
|
(75)
|
(89)
|
(93)
|
(85)
|
(87)
|
(79)
|
(600)
|
(598)
|
(598)
|
(615)
|
(116)
|
(162)
|
(197)
|
(221)
|
(241)
|
(746)
|
(922)
|
(1 080)
|
|
| Depreciation & Amortization |
1
|
1
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
2
|
2
|
2
|
3
|
4
|
7
|
13
|
16
|
15
|
15
|
12
|
11
|
10
|
8
|
14
|
21
|
30
|
49
|
51
|
53
|
520
|
632
|
732
|
|
| Other Non-Cash Items |
2
|
2
|
2
|
2
|
6
|
8
|
15
|
21
|
21
|
22
|
27
|
551
|
546
|
544
|
540
|
20
|
45
|
59
|
64
|
62
|
516
|
629
|
725
|
|
| Cash Taxes Paid |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
2
|
5
|
8
|
11
|
11
|
7
|
4
|
9
|
7
|
7
|
7
|
0
|
|
| Change in Working Capital |
(1)
|
(2)
|
1
|
(2)
|
2
|
(6)
|
(0)
|
(1)
|
(9)
|
7
|
9
|
12
|
6
|
1
|
(2)
|
2
|
19
|
24
|
15
|
5
|
23
|
22
|
31
|
|
| Cash from Operating Activities |
(35)
N/A
|
(47)
-34%
|
(48)
-2%
|
(69)
-43%
|
(64)
+6%
|
(71)
-11%
|
(73)
-2%
|
(71)
+2%
|
(71)
0%
|
(56)
+21%
|
(42)
+26%
|
(36)
+14%
|
(46)
-28%
|
(52)
-14%
|
(77)
-47%
|
(94)
-22%
|
(97)
-4%
|
(113)
-16%
|
(142)
-26%
|
(173)
-22%
|
(207)
-19%
|
(270)
-30%
|
(323)
-20%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(1)
|
(1)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(645)
|
(645)
|
(648)
|
(588)
|
77
|
(123)
|
(228)
|
(205)
|
(65)
|
286
|
395
|
(174)
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
+20%
|
(0)
-20%
|
(0)
-10%
|
(0)
+39%
|
(0)
+14%
|
(0)
-29%
|
(1)
-103%
|
(1)
-22%
|
(1)
+3%
|
(1)
+17%
|
(645)
-103 984%
|
(645)
+0%
|
(648)
-1%
|
(588)
+9%
|
77
N/A
|
(123)
N/A
|
(228)
-85%
|
(205)
+10%
|
(65)
+68%
|
286
N/A
|
394
+38%
|
(174)
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||||||||
| Net Issuance of Common Stock |
25
|
25
|
51
|
52
|
127
|
127
|
78
|
77
|
2
|
102
|
100
|
206
|
206
|
106
|
112
|
7
|
207
|
487
|
481
|
488
|
290
|
45
|
618
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
55
|
0
|
0
|
0
|
(30)
|
25
|
0
|
520
|
470
|
470
|
495
|
(25)
|
0
|
0
|
(76)
|
(100)
|
0
|
0
|
(25)
|
0
|
|
| Other |
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
25
N/A
|
25
N/A
|
51
+102%
|
106
+111%
|
127
+19%
|
127
+1%
|
78
-39%
|
47
-39%
|
27
-43%
|
101
+274%
|
620
+511%
|
675
+9%
|
675
0%
|
600
-11%
|
87
-86%
|
7
-92%
|
207
+2 908%
|
411
+98%
|
381
-7%
|
388
+2%
|
190
-51%
|
20
-89%
|
618
+2 972%
|
|
| Change in Cash | ||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(3)
|
(1)
|
1
|
1
|
5
|
3
|
0
|
(0)
|
(1)
|
(3)
|
(1)
|
(1)
|
0
|
2
|
1
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
(14)
N/A
|
(23)
-69%
|
3
N/A
|
38
+1 387%
|
67
+75%
|
59
-12%
|
5
-91%
|
(25)
N/A
|
(46)
-86%
|
42
N/A
|
577
+1 283%
|
(6)
N/A
|
(15)
-135%
|
(98)
-545%
|
(577)
-488%
|
(9)
+98%
|
(13)
-43%
|
70
N/A
|
34
-52%
|
150
+345%
|
269
+79%
|
145
-46%
|
120
-17%
|
|
| Free Cash Flow | ||||||||||||||||||||||||
| Free Cash Flow |
(35)
N/A
|
(47)
-34%
|
(49)
-2%
|
(69)
-43%
|
(65)
+6%
|
(72)
-11%
|
(73)
-2%
|
(72)
+2%
|
(72)
0%
|
(57)
+21%
|
(42)
+26%
|
(36)
+15%
|
(46)
-27%
|
(52)
-14%
|
(77)
-47%
|
(94)
-22%
|
(98)
-4%
|
(113)
-16%
|
(142)
-26%
|
(174)
-22%
|
(207)
-19%
|
(270)
-30%
|
(324)
-20%
|
|